The effect of the combined treatment with dulaglutide and dapagliflozin in arterial elasticity, cardiac function, albuminuria and endothelial thickness in type 2 diabetes mellitus after 12 months

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speakers

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

Doctor Konstantinos Katogiannis

Attikon University Hospital, Athens (Greece)

5 More presentations in this session

Presentation thumbnail

Characterization of individuals with atherosclerotic cardiovascular disease, with and without chronic kidney disease: results from a UK electronic health record database

Professor N. Sattar (Glasgow, GB)

Abstract Slides Video

Presentation thumbnail

Coronary artery disease screening in renal transplant candidates: insights from a large prospective cohort

Mr L. Giovachini (Paris, FR)

Abstract Slides Video

Presentation thumbnail

Renal hyperfiltration as risk factor of major adverse cardiovascular events in patients with acute myocardial infarction

Professor W. Kim (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Mapping renal impairment and cardiac structure and function: observation and genetic insights from 30,000 cardiac magnetic resonance images

Doctor X. Lu (Guangzhou, CN)

Abstract Slides Video

Presentation thumbnail

Much ado about nothing: the impact of coronary angiography on kidney function in individuals with chronic kidney disease

Doctor O. Dirir (Sheffield, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Coronary artery disease in kidney patients: from genes to treatment

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources